StockTipsArenaBeta

BUY Supriya Lifescience Limited — Siddharth Rai Mangala

BUYSupriya Lifescience Limited
Supriya Lifescience share price target & all analyst calls

bySiddharth Rai MangalaHorizon: NA (inferred Swing (≤2wk))20 Aug 2026via Zee Business (Live)

Entry₹820Inferred
Target₹960
Total upside +17.07% (call closed)
Stop loss₹770-6.10% risk
At expiry₹843.052 Sept 2026, 3:30 pm
Expired+2.81%
Follow Siddharth Rai Mangala for new calls(29% target hit, 176 closed calls)Get alertsWatch SUPRIYA for new buy/sell callsGet alertsSee 147 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 2 Sept 2026
4 supporting4 opposing
Supports the BUY call (4)

Supriya Lifescience announces Q1 FY27 results with revenue at ₹1,897.5 million

NewsGoogle News·13 Aug · 3w ago

(opens in new tab)

Supriya Lifescience: Q1 FY27 Profit Soars 196% to ₹240 Crore

NewsGoogle News·13 Aug · 3w ago

(opens in new tab)

Supriya Lifescience: Q1 FY27 Revenue Jumps 144% to ₹1,897 Cr

NewsGoogle News·13 Aug · 3w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·6 Jul · 2mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (4)

సుప్రియా లైఫ్‌సైన్స్: రెవెన్యూలో దూకుడు, కానీ లాభాల్లో తగ్గుదల! కారణమేంటి?

NewsGoogle News·18 Aug · 2w ago

(opens in new tab)

Supriya Lifescience के शेयर में गिरावट! रेवेन्यू बढ़ा पर प्रॉफिट घटा, जानें वजह

NewsGoogle News·18 Aug · 2w ago

(opens in new tab)

Supriya Lifescience Share: આવક વધી પણ નફો ઘટ્યો, રોકાણકારો માટે શું છે સારા સમાચાર?

NewsGoogle News·18 Aug · 2w ago

(opens in new tab)

Supriya Lifescience Q1 Net Profit Drops To 240M Rupees From 348M YoY

NewsGoogle News·13 Aug · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Supriya Lifescience

All analyst calls on Supriya Lifescience

More from Siddharth Rai Mangala

Every call and its outcome